Sana Biotechnology Q3 Adj. EPS $(0.14) Beats $(0.15) Estimate
Benzinga Newsdesk 5 days ago
NewsEarningsEarnings Beats
Sana Biotechnology (NASDAQ:SANA) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.15) by 6.67 percent. This is a 6.67 percent increase over losses of $(0.15) per share from
Sana Biotechnology (NASDAQ:SANA) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.15) by 6.67 percent. This is a 6.67 percent increase over losses of $(0.15) per share from the same period last year.